Liver Transplantation for Hepatic Metastases

  • Hauke Lang
  • Karl Jürgen Oldhafer
  • Hans Jürgen Schlitt
  • Rudolf Pichlmayr


The results of hepatic resection for secondary liver tumours have (steadily) improved as a result of advances in surgical technique, perioperative management and diagnostic modalities which enable an earlier and more accurate detection of liver metastasis. Despite the development of extracorporeal liver surgery which enables the possibility of removing centrally located or multilocular intrahepatic tumours, only a small number of patients with secondary hepatic tumours are candidates for radical surgery.1


Liver Transplantation Hepatic Metastasis Carcinoid Tumor Vasoactive Intestinal Polypeptide Liver Grafting 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pichlmayr R, Grosse H, Hauss J, Gubernatis G, Lamesch P, Bretschneider HJ. Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver. Br J Surg 1990; 77:21–26.PubMedCrossRefGoogle Scholar
  2. 2.
    Bechstein WO, N euhaus P. Liver transplantation for hepatic metastases of neuroendocrine tumors. Ann New York Acad Sci 1994; 733:507–514.CrossRefGoogle Scholar
  3. 3.
    O’Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecu -tive patients. Ann Surg 1989; 207:373–379.CrossRefGoogle Scholar
  4. 4.
    Pichlmayr R, Weimann A, Oldhafer KJ et al. Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg 1995; 19:807–813.PubMedCrossRefGoogle Scholar
  5. 5.
    Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlmayr R. The ro1e of liver transplantation in hepatobil iary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 1989; 209:88–98.PubMedCrossRefGoogle Scholar
  6. 6.
    Pichlmayr R, Weimann A, Ringe B. Indications for liver transplantation in hepatobiliary malignancy. Hepatology 1994; 20:33.Google Scholar
  7. 7.
    European Liver Transplant Registry December 1995.Google Scholar
  8. 8.
    Penn I. Hepatic Transplantation for primary and metastatic cancers of the liver. Surgery 1991; 110:726–735.PubMedGoogle Scholar
  9. 9.
    Iwatsuki S, Tzakis A, Todo S, Se1by R, Starzl TE. Liver trans plantation for metastatic hepatic malignancies. Hepatology 1993; 18:723.Google Scholar
  10. 10.
    Pichlmayr R. Is there a place for liver grafting for malig nancy? Transplant Proc 1988;20:478–482.PubMedGoogle Scholar
  11. 11.
    Mühhlbacher F, Piza F. Orthotopic liver Transplantation for secondary malignancies of the liver. Transplant Proc 1987;19(1):2396–2398.Google Scholar
  12. 12.
    Lang H, Oldhafer KJ, Duebener L, Ringe B, Pichlmayr R. The role of liver Transplantation in the treatment of metastatic hepatic tumors. Br J Surg 1994;81(Suppl 1):87Google Scholar
  13. 13.
    Ollthoff KM, Millis M, Rosove MH, Goldstein LI, Ramming KP, Busuttil RW. is liver Transplantation justified for the treatment of hepatic malignancies? Arch Surg 1990;125:1261–1268.Google Scholar
  14. 14.
    Alessiani M, Tsakis A, Todo, Demetris AJ, Fung JJ, Starzl TE. Assessment of five-year experience with abdominal organ cluster Transplantation. J Am Coll Surg 1995; 180:1.PubMedGoogle Scholar
  15. 15.
    Ahlman H, Westberg G, Wangberg B, Nilsson O, Tylen U, Schersten T. Treatment of liver metastases of carcinoid tumors. World J Surg 1996; 20:196–202PubMedCrossRefGoogle Scholar
  16. 16.
    Arnold R. Medical treatment of metastasizing carcinoid tumors. World J Surg 1996; 20:203–207.PubMedCrossRefGoogle Scholar
  17. 17.
    Delcore R, Friesen SR. Gastrointestinal neuroendocrine tumors.J Am Coll Surg 1994; 178:187–211.PubMedGoogle Scholar
  18. 18.
    Hajarizadeh H, Ivancev K, Mueller CR, Fletscher WS, Woltering EA. Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate. Am J Surg 1992; 163:479–482.PubMedCrossRefGoogle Scholar
  19. 19.
    Kvols LK,Buck M. Chemotherapy of metastatic carcinoid and islet cell tumors. Am J Med 1987;82(Suppl 5B):77–83PubMedCrossRefGoogle Scholar
  20. 20.
    Kvols LK.Moerter CG, O’Connell MJ, Schutt AJ, Rubin J, Hahn RG.Treatment of the malignant carcinoid syndrome. Evaluation of along acting somatostatin analogue,N Engl J Med 1986; 315:663–666Google Scholar
  21. 21.
    Martin K Jr, Moertel CG, Adson MA, Schutt AJ. Surgical treatment of functioning metastatic carcinoid tumors. Arch Surg 1993; 118:537–542.Google Scholar
  22. 22.
    McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990; 108:1091–1096.PubMedGoogle Scholar
  23. 23.
    Moertel CG. Karnofsky Memorial Lecture:an odyssey in the land of small tumors. J Clin Oncol 1987; 5:1503–1522.Google Scholar
  24. 24.
    Moertel CG, Johnson CM, McKusick MA et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 1994; 120:302–309.PubMedGoogle Scholar
  25. 25.
    Moertel CG, Lefkopoulo M, Lipsitz S, Hahn RG, Klaassen D. Streptozocin-doxorubicin, streptozocin-fluorouracil, or chlorozotocin in the treatment of advanced is let-cell carcinoma. N Engl J Med 1992; 326:519–523.PubMedCrossRefGoogle Scholar
  26. 26.
    Makowka L, Tzakis AG, Mazzaferro V et al. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet 1989; 168:107–111.PubMedGoogle Scholar
  27. 27.
    Arnold JC, O'Grady JG, Bird GL, Calne RY, Williams R. Liver Transplantation for primary and secondary hepatic apudomas. Br J Surg 1989; 76:248–249.PubMedCrossRefGoogle Scholar
  28. 28.
    Lang H, Oldhafer KJ, Weimann A et al. Liver Transplantation for metastatic neuroendocrine tumors. Ann Surg 1997;225:347–354.PubMedCrossRefGoogle Scholar
  29. 29.
    Lang H, Oldhafer KJ,Schlitt HJ, Scheumann GFW, Ringe B, Pichlmayr R. Ist die LeberTransplantation als chirurgisches Therapiekonzept bei Metastasen neuroendokriner Tumoren gerechtfertigt? Langenbecks Arch Chir 1996; Suppl II. 416–418.Google Scholar
  30. 30.
    Le Treut YP, Delpero JP, Houssin D et al. Is liver Transplantation (OLT) a rational approach for neuroendocrine metastases (NEM)? Report of a French multicentric study of 31 cases. HPB Surgery 1996;9(Suppl 2):19.Google Scholar
  31. 31.
    Margreiter R, Niederwieser D, Frommhold H, Schönitzer A,Huber C. Tumor recurrence after liver Transplantation followed by high-dose cyclophosphamide, total body irradiation, and autologous bone marrow Transplantation for treatment of metastatic liver disease. Transplant Proc 1987;19(1):2403–2404.PubMedGoogle Scholar
  32. 32.
    Starzl TE, Todo S, Tzakis A et al. Abdominal organ cluster Transplantation for the treatment of upper abdominal malignancies. Ann Surg 210:374–386.Google Scholar
  33. 33.
    Knechtle SJ, Kalayoglu M, D’Alessandro AM et al. Should abdominal cluster Transplantation be abandoned? Transplant Proc 1993; 25:1361–1363.PubMedGoogle Scholar
  34. 34.
    Wenisch HJC, Markus BH, Herrmann GH, Usadel KH, Encke A. Multiviscerale Oberbauchresektion und orthotope LeberTransplantation-ein chirurgisches Behandlungskonzept für regionär metastasierende Tumoren des endocrinen Pancreas. Zentbl Chir 1992;117:334–342.Google Scholar
  35. 35.
    Gulanikar AC, Kotylak G, Bitter-Suermann H. Does immuno suppression alter the growth of metastatic liver carcinoid after orthotopic liver Transplantation? Transplant Proc 1991; 23:2197–2198.PubMedGoogle Scholar
  36. 36.
    Soreide O, Berstad T, Bakka A. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors.Surgery 1992;111:48–54.Google Scholar
  37. 37.
    Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995; 169:36–43.PubMedCrossRefGoogle Scholar
  38. 38.
    Perry LJ, Stuart K, Stokes KR, Clouse ME. Hepatic arterial chemoembolization for metastastic neuroendocrine tumors. Surgery 1994,166:1111–1117.Google Scholar
  39. 39.
    Alsina AE, Bartus S, Hall D. Liver Transplantation for metastatic neuroendocrine tumors. J Clin Gastroenterol 1990; 12:533–537.PubMedCrossRefGoogle Scholar
  40. 40.
    Farmer DG, Shaked A, Colonna JO. Radical resection combined with liver Transplantation for foregut tumors. Am J Surg 1993; 59:806–812.Google Scholar
  41. 41.
    Anthuber M, Jauch KW, Briegel J et al. Results of liver transplantation for gastroenteropancreatic tumor metastases. World J Surg 1996; 20:73–76.PubMedCrossRefGoogle Scholar
  42. 42.
    Curtiss SI, Mor E, Schwartz ME et al. A rational approach to the use of hepatic Transplantation in the treatment of metastatic neuroendocrine tumors. J Am Coll Surg 1995; 180:184–187.PubMedGoogle Scholar
  43. 43.
    Dousset B, Saint-Marc O, Pitre J, Soubrane O, Houssin D, Chapuis Y. Metastatic endocrine tumors:medical treatment,surgical resection, or liver Transplantation. World J Surg 1996;20:908–915PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 1998

Authors and Affiliations

  • Hauke Lang
  • Karl Jürgen Oldhafer
  • Hans Jürgen Schlitt
  • Rudolf Pichlmayr

There are no affiliations available

Personalised recommendations